Abstract:Objective To study the expression of special AT-rich sequence-binding protein 1(SATB1) gene and its relationship with SLC22A18 protein expression in astrocytoma.Methods Fifty-six patients with astrocytomas (12 with grade Ⅰ,13 with grade Ⅱ,15 with grade Ⅲ,and 16 with grade Ⅳ),performed surgical excision in our hospitals from September 2006 to June 2010 and from September 2003 to June 2006,were chosen in our study; another 10 brain tissues from patients performed decompression operation resulting from cerebral hernia were selected as the controls.RT-PCR and Western blotting were used to detect the mRNA and protein expressions of SATB1.The SLC22A18 protein expression was detected by immunohistochemical assay.The relations between SLC22A18expressions and SA TB1 levels,and these two and the degree of malignancy were analyzed.Results RT-PCR and Western blotting revealed that positive mRNA and protein expressions were noted in 35patients with astrocytomas; the mRNA and protein expression rate and value of SATB1 in the astrocytoma tissues were significantly different among different grades of tumors (P＜0.05); the higher the malignancy grade,the higher mRNA and protein expression rate and value ofSA TB1; the protein expression value of SA TB1 had a positive correlation with the malignancy grade of tumors (r=0.987,P=0.000).And a few expressions of SA TB1 mRNA and protein were found in the tissues of controls.Immunohistochemical assay indicated that positive protein expression of SLC22A18 was noted in 19 astrocytoma tissues,and the protein expression rate of SLC22A18 in the astrocytoma tissues was significantly different among different grades of tumors (P＜0.05); the higher the malignancy grade,the lower expression of SLC22A18.And the protein expression of SLC22A18 was found in all the tissues of controls.The SATB1 expression rate in the tissues with negative SLC22A18 expression (81.1％) was significantly higher than that in the tissues with positive SLC22A18 expression (26.3％,P＜0.05).Conclusion SATB1 expresses in the astrocytoma tissues,indicating that it may play an important role in the pathogenesis of astrocytoma;up-regulation of SATB1 expression and dysfunction of SLC22A18 may play synergetic roles in the process of carcinogenesis of astrocytoma.

Influence of SLC22A18 Gene Expression on the Biological Behaviors of Glioma Cells

Effects of SLC22A18 Gene on Chemosensitivity of U251 Human Glioma Cells

Influence of Small Interfering RNA-mediated Inhibiting Human Runt-Related Transcription Factor 2 and Galectin-3 Gene on Proliferation and Apoptosis of Glioma Cell U251

Elevated Expression of Solute Carrier Family 22 Member 18 Increases the Sensitivity of U251 Glioma Cells to BCNU

Promoter Methylation and Downregulation of SLC22A18 Are Associated with the Development and Progression of Human Glioma

Relationship Between Aberrant Methylation of SLC22A18 Gene Promoter and SLC22A18 Expression in Glioma

Effect of solute carrier family 8, member 2 on invasion, migration and in vivo xenograft growth of glioma cell line U87

In Vitro and in Vivo Radiosensitization of Human Glioma U251 Cells Induced by Upregulated Expression of SLC22A18

Evaluation of Combination Gene Therapy with SLC22A18 Upregulation and Sequence Binding Protein 1 Downregulation for Glioma U251 Cells in Vitro and in Vivo

Correlation of Low SLC22A18 Expression with Poor Prognosis in Patients with Glioma.

Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in Glioma U251 Cells.

Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma

The Expression of SALL4 in Patients with Gliomas: High Level of SALL4 Expression is Correlated with Poor Outcome

Influence of Special AT-rich Sequence Binding Protein 1 Silencing on the Invasion of Glioma U251 Cells

The hsa_circ_0024183 may affects glioblastoma progression by interacting with the protooncogene SALL4

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas

Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas

The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.

Expression of Special AT-rich Sequence-Binding Protein 1 Gene and Its Relationship with SLC22A18 Protein Expression in Astrocytoma

The Effect and Mechanism of LINC00663 on the Biological Behavior of Glioma

Overcoming acquired resistance by SLC22A18 silencing in human glioma